Lv5
1010 积分 2025-10-03 加入
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
1小时前
已完结
Repeatability and reproducibility of artificial imaging based digital pathology for the evaluation of liver fibrosis
1小时前
求助中
Definition and diagnostic criteria of clinical obesity
1小时前
求助中
Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH
1小时前
已完结
皖公网安备34019202002308
